Biogen reports Leqembi Alzheimer's drug sales reached $96M in Q1, up from $19M last year, with $52M from US market. Eisai ...

Stately Bio has raised a $12 million seed round led by AIX Ventures to advance machine learning techniques that recognize ...

Moderna is expanding a cost control program as it seeks to break even in the coming years, despite challenges for vaccine ...

Teladoc has bought virtual therapy startup UpLift to sell mental health treatment, including treatment from its ...

Artios Pharma, a startup developing drugs that weaken a tumor’s ability to maintain its DNA, announced positive results in a ...

Top cancer scientists, former NIH leaders, and patient advocates warned that the Trump administration's cuts to science ...

GSK said its decoupling with Haleon is a key reason why it views itself as “well-positioned” in the face of potential ...

Noma Therapy, a virtual ketamine-assisted therapy provider, has launched with $4.25 million in funding, Endpoints News ...

Merck is shifting manufacturing for its blockbuster drug Keytruda to a new $1 billion factory in Delaware, doubling down on ...

Pfizer CEO Albert Bourla gave an optimistic read on Tuesday when asked how he thought the trade levies might be implemented.

Live stream podcast tomorrow at 12pm ET with Drew Armstrong, Max Bayer & Anna Brown discussing pharma industry's response to ...

Devoted Health shows growth in 2024 with increased membership and revenue while reducing operating losses, contrasting with ...